Ngaio Diagnostics
Ngaio Diagnostics is a Nelson, New Zealand-based specialty distributor of diagnostic products from 50+ global manufacturers — with exclusive NZ rights for ALIFAX — serving clinical, veterinary, food safety, and environmental laboratories across New Zealand, Australia, and the Pacific Islands.
- Company typePrivate
- Founded1991
- HeadquartersNelson, New Zealand
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Ngaio Diagnostics does
Ngaio Diagnostics is a privately held specialty distribution company headquartered in Nelson, New Zealand, that supplies and supports diagnostic products for clinical, veterinary, food and beverage, life science, point-of-care, and environmental laboratories across New Zealand, Australia, and the Pacific Islands. Founded in 1991 by Rob McKenzie, the company operates as a multi-brand distributor representing over 50 global manufacturers — including exclusive New Zealand rights for ALIFAX S.r.l microbiology platforms (Alfred 60/AST, i-dOne, Molecular Mouse) — alongside its own NgaioDx branded rapid test kits (COVID-19 antigen, calf scour, Strep A, urinalysis and pH strips).
The company's technology footprint is that of a value-added distributor rather than an instrument developer. Ngaio's portfolio spans third-party automated microbiology workstations, molecular isothermal amplification kits (Pluslife), NGS library prep (Zymo Research), ATP hygiene monitoring (Hygiena), bacterial serotyping antisera (Sifin), urine diagnostics (Analyticon), plant pathogen and GMO testing (Agdia), and New Zealand-manufactured BSA (MP Biomedicals). Its own NgaioDx branded products — including the AxCSSS five-pathogen calf scour test and COVID-19 rapid antigen kits — represent a modest proprietary product line sold via the shop.ngaio.co.nz e-commerce storefront.
Ngaio generates revenue primarily through B2B distribution margins on hardware and consumable sales, with quote-based pricing for enterprise/laboratory customers and unit-pricing for SMB/consumer purchases through its online shop. The business is sales-led, with a technical sales team covering clinical diagnostics, life science, food and beverage, point-of-care, and veterinary segments. Headcount is in the 51–100 range and the company remains founder/family-owned under the McKenzie family with no disclosed external institutional capital, no funding rounds, and no revenue disclosure.
Ngaio Diagnostics firmographics
Firmographics- Name
- Ngaio Diagnostics
- Legal name
- Ngaio Diagnostics Ltd.
- Website
- https://ngaio.co.nz
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Ngaio Diagnostics is a Nelson, New Zealand-based specialty distributor of diagnostic products from 50+ global manufacturers — with exclusive NZ rights for ALIFAX — serving clinical, veterinary, food safety, and environmental laboratories across New Zealand, Australia, and the Pacific Islands.
- Ownership category
- akta.pro rank
Ngaio Diagnostics industry classification
Industry- Product category
- Diagnostic Products Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)
- akta.pro secondary industries
- Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA), Supplier Approval, Verification & Food Safety Risk Management (GFSI-aligned) (AFALADAH), Urinalysis & Routine Screening Diagnostics (HLAHAAAG)
Keywords
Where Ngaio Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Nelson
- HQ country
- New Zealand
- HQ region
- Oceania
Offices1 record
Markets served
Ngaio Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Product Distribution: Distribution and support of diagnostic products to laboratories and commercial users, generating revenue through product markups and distribution margins on sales of third-party diagnostic products throughout New Zealand, Australia, and Pacific Islands.
- E-commerce Online Sales: Direct-to-consumer and SMB sales through their online shop (shop.ngaio.co.nz) offering selected products including rapid antigen tests, urinalysis strips, pH test strips, calf scour test kits, and other diagnostic supplies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Individual consumer/SMB products via online shop |
| Other | Multi-year contract | B2B laboratory and commercial orders |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Ngaio Diagnostics product offering
Product offeringCore offering
Ngaio Diagnostics is a privately owned distribution company that specialises in supplying and supporting quality diagnostic products from more than 50 global manufacturers to clinical, research, food and beverage, veterinary, and environmental laboratories across New Zealand, Australia, and the Pacific Islands. The company sells both NgaioDx-branded rapid diagnostic tests (COVID-19 RATs, calf scour kits, Strep A tests, pH and sulfite strips) and distributed third-party products, providing local technical support, study design assistance, and educational resources alongside product supply.
Product overview
Ngaio Diagnostics is a distribution company specializing in diagnostic products for laboratories and commercial users across New Zealand, Australia, and the Pacific Islands. Their product portfolio includes both their own NgaioDx branded rapid diagnostic tests (COVID-19 RATs, Healgen combination tests, calf scour test kits, Strep A tests, pH and sulfite test strips) and distributed products from over 60 global manufacturers. Their online shop offers a selected range of products directly to consumers, while the full portfolio spans clinical diagnostics, life sciences, food and beverage testing, drug and point-of-care testing, veterinary diagnostics, and environmental applications. The company provides technical support, study design assistance, and educational resources alongside their product distribution.
Differentiator
Problem solved
Functional benefit
Brands
- NgaioDx AxCSSS Rapid Calf Scour Test: Rapid diagnostic test kit for detecting five major calf scour pathogens (Bovine Coronavirus, Bovine Rotavirus, Cryptosporidium, Giardia, and E. coli K99) on-farm
- NgaioDx COVID RAT
- AlbumiNZ BSA
Products and services
- NgaioDx Rapid Calf Scour Test Kit A rapid on-farm diagnostic tool for detecting Bovine Coronavirus, Bovine Rotavirus, Cryptosporidium, Giardia, and Escherichia coli K99 antigens in calf fecal samples, delivering results in approximately 10 minutes. Aimed at veterinary clinics and farmers during calving season.
- NgaioDx COVID-19 Rapid Antigen Test Kit (5 pack) OrientGene COVID-19 antigen rapid test cassette for nasal swab specimens, providing qualitative detection of COVID-19 antigen with results in 15 minutes. Authorized for self-testing and professional use in New Zealand.
- Healgen 4-in-1 COVID-19, Flu A&B, RSV Rapid Test Rapid combo test cassette for simultaneous qualitative detection of COVID-19, Influenza A, Influenza B, and RSV antigens from nasal swab specimens, delivering results within 15 minutes.
- Combiscreen Urinalysis Test Strips Semi-quantitative urine test strips from Analyticon for measuring multiple analytes including glucose, protein, ketones, bilirubin, leukocytes, nitrite, pH, urobilinogen, blood, and specific gravity, used for assessment of metabolism, kidney and liver function, and urinary tract infections.
- Glucose/Protein Dipsticks Analyticon urine test strips for glucose and protein detection, offering modern, cost-efficient urine diagnosis with German manufacturing and market-leading performance.
- Rapid Strep A (GAS) Test Kit (20 tests) Ngaio rapid chromatographic immunoassay for qualitative presumptive detection of Streptococcus pyogenes (Group A Strep) antigen from throat swab specimens, delivering results within 5 minutes.
- pH 1-14 Test Strips (100) Wide-range pH test strips with vivid color chart for easy pH determination from 1.0 to 14.0, packaged in moisture-wicking flip-up vials for field and laboratory use.
- Free Sulfite Test Strips Rapid (10-500 ppm) Rapid test strips for detecting sulfite ions in water-based solutions, measuring concentrations from 10 to 500 ppm, used for sulfite detection in foods and beverages.
- Chain of Custody (COC) Forms Triplicate form books for chain of custody documentation in drug and alcohol testing, containing 25 sets of white (Collector), pink (Donor), and yellow (Employer) pages.
Quantifiable outcome
- Support provided for studies, trials, and research projects including study design, product selection, and regulatory considerations
Companies that use Ngaio Diagnostics
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles5 records
Ngaio Diagnostics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Ngaio Diagnostics partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- ALIFAX S.r.lcoreExclusive distribution agreement positioning Ngaio Diagnostics as the official and exclusive distributor for ALIFAX's Microbiology product line in New Zealand, including the Alfred 60/AST (fully automated microbiology workstation), i-dOne (rapid microorganism identification), and Molecular Mouse (compact real-time PCR platform) systems. This partnership strengthens their clinical microbiology offerings with automated, rapid diagnostic solutions.
- PluslifecoreNgaio has been an official channel partner/distributor for Pluslife products since 2023. Pluslife specializes in nucleic acid isothermal amplification detection technology offering molecular results comparable to traditional PCR tests. Products include diagnostic kits for respiratory diseases (SARS-CoV-2, Influenza A/B, RSV, TB) and sexually transmitted infections (chlamydia, gonorrhea, HPV).
- MicrobiumminorNgaio announced partnership with Microbium to introduce their Water MPN Analyser to New Zealand. The unique automated system delivers quantitative water testing results for E. coli and Coliform in 4 easy steps, conforming with ISO 9308-2.
- Zymo ResearchcoreZymo Research is a global biotechnology leader in epigenetics, microbiomics, and Next-Gen Sequencing. Ngaio distributes their products including NGS library prep kits, paperless protocol QR codes, and sustainable sample shipping solutions.
- HygienacoreHygiena offers ATP testing solutions, micro and pathogen screening tools, allergen and mycotoxin assays, environmental sampling devices, PCR testing and integrated data-analytics software.
- SifincoreSifin produces a wide range of antisera for Salmonella, Shigella, Yersinia and Coli diagnosis, along with blood grouping reagents, culture media, additives and supplements.
- AnalyticoncoreAnalyticon provides urine dip strips, readers for both high and low volumes, clinical chemistry reagents, calibrators and controls.
- AgdiacoreAgdia has been a leading provider of plant pathogen diagnostics since 1981, offering comprehensive portfolio of plant pathogen and GMO testing solutions.
- MP BiomedicalscoreMP Biomedicals produces AlbumiNZ, a premium brand of Bovine Serum Albumin (BSA) manufactured in New Zealand using advanced chromatographic techniques.
- Fuse DiagnosticsminorFuse develops Flip Mycoplasma rapid tests for cell culture laboratories - instrument-free tests delivering laboratory-quality results in 12 minutes.
- ZeulabcoreZeulab offers antibiotic residue testing solutions for milk and meat, allergen testing, pathogen detection, and quality control testing for food safety.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Ngaio Diagnostics competitors and assessment
Company assessmentBroad incumbents
- Thermo Fisher Scientific: Largest global life sciences tools and diagnostics supplier, serving clinical, food safety, and research laboratories. Ngaio's customer base and product categories (molecular biology reagents, lab consumables) overlap with Thermo Fisher's portfolio, though Ngaio focuses on regional distribution of niche brands.
- QIAGEN: Global provider of sample preparation and molecular diagnostics products for life sciences and clinical applications. Ngaio distributes competitive products in molecular biology and NGS sample prep (e.g., from Zymo Research) that overlap with QIAGEN offerings to NZ labs.
- Bio-Rad Laboratories: Global life science and clinical diagnostics manufacturer and supplier with broad product portfolio across molecular biology, food safety, and clinical diagnostics. While Ngaio distributes competing brands (e.g., Zymo, ALIFAX), Bio-Rad is a representative large incumbent in the same end-customer lab market.
- IDEXX Laboratories: Global leader in veterinary diagnostics, including rapid tests and laboratory equipment. Ngaio's veterinary vertical (calf scour tests, vet clinic supplies) competes with and complements IDEXX products across the same NZ vet market.
- Merck Life Science (Sigma-Aldrich): Global supplier of life science products, reagents, and lab consumables. Ngaio's lab supply portfolio (molecular biology reagents, biochemicals) competes with and complements Merck products across the same research and clinical lab customers.
Direct peers
- Bio-Strategy: New Zealand and Australia-based distributor of laboratory, life science, and diagnostic products. Directly comparable specialty distributor serving the same Australasian lab market with similar multi-brand portfolio approach.
- DKSH: Asia-Pacific market expansion services specialist with significant diagnostics and scientific products distribution operations. Similar business model of bringing global manufacturers into regional markets with technical sales support.
- Abacus dx: Australia and New Zealand-based distributor of diagnostic and life science products to clinical and research laboratories. Most directly comparable peer to Ngaio — same region, same customer segments, similar specialty distribution model.
- In Vitro Technologies: Australian distributor of in vitro diagnostics and life science products serving clinical and research laboratories. Closely comparable specialty distributor in the same Oceania geography with overlapping manufacturer relationships.
Emerging players
- Hygiena (direct subsidiary of Bio-Techne): Ngaio's existing distribution partner and global supplier of ATP testing, allergen assays, and food safety diagnostics. Listed as a peer because the same products Ngaio distributes are sold direct by Hygiena in larger markets, illustrating the structural disintermediation risk Ngaio faces.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Ngaio Diagnostics social profiles
Digital presenceNgaio Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ngaio Diagnostics leadership team
Management profileNumber of profiles
Profiles12 records
Ngaio Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ngaio Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ngaio Diagnostics
What does Ngaio Diagnostics do?
Ngaio Diagnostics is a privately owned distribution company that specialises in supplying and supporting quality diagnostic products from more than 50 global manufacturers to clinical, research, food and beverage, veterinary, and environmental laboratories across New Zealand, Australia, and the Pacific Islands. The company sells both NgaioDx-branded rapid diagnostic tests (COVID-19 RATs, calf scour kits, Strep A tests, pH and sulfite strips) and distributed third-party products, providing local technical support, study design assistance, and educational resources alongside product supply.
Is Ngaio Diagnostics a public or private company?
Ngaio Diagnostics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Ngaio Diagnostics founded?
Ngaio Diagnostics was founded in 1991. It employs 51 to 100 people.
Where is Ngaio Diagnostics based?
Ngaio Diagnostics is headquartered in Nelson, New Zealand, in the Oceania region.
How does Ngaio Diagnostics make money?
Two revenue lines are on record. Product Distribution is the primary driver. The others are E-commerce Online Sales.
Who are Ngaio Diagnostics's main competitors?
Broad incumbents on record are Thermo Fisher Scientific, QIAGEN, Bio-Rad Laboratories, IDEXX Laboratories and Merck Life Science (Sigma-Aldrich). Direct peers are Bio-Strategy, DKSH, Abacus dx and In Vitro Technologies. Hygiena (direct subsidiary of Bio-Techne) is listed as an emerging player.
Does Ngaio Diagnostics have an API?
No public API is recorded for Ngaio Diagnostics.
What industry is Ngaio Diagnostics in?
Ngaio Diagnostics's product category is Diagnostic Products Distribution. Its primary akta.pro industry code is HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR), with a secondary code of HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services. Its NAICS code is 42421 and its SIC code is 5047.